|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.00 EUR | -.--% |
|
-.--% | - |
| 24/09/25 | PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 11/09/25 | PharmaSGP Holding SE Reaffirms Earnings Guidance for the Financial Year 2025 | CI |
| 1 year | 28 |  | 30 |
| 3 years | 17.7 | | 30 |
| 5 years | 17.7 | | 30 |
| 10 years | 14.4 | | 36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 01/01/2025 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Axel Rebien
BRD | Director/Board Member | 55 | 01/06/2020 |
Clemens Fischer
CHM | Chairman | 51 | 04/03/2020 |
| Director/Board Member | 45 | 04/03/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 447M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | -0.06% | +0.54% | +28.54% | +53.91% | 397.23B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
Employees
98
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PSG Stock
- PSG Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
